Cite
HARVARD Citation
Scangarella-Oman, N. et al. (2023). Dose selection for a phase III study evaluating gepotidacin (GSK2140944) in the treatment of uncomplicated urogenital gonorrhoea. Sexually transmitted infections. pp. 64-69. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Scangarella-Oman, N. et al. (2023). Dose selection for a phase III study evaluating gepotidacin (GSK2140944) in the treatment of uncomplicated urogenital gonorrhoea. Sexually transmitted infections. pp. 64-69. [Online].